AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33436117 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomised trials in 1998
Number of subjects: 2046
Study 33436117 — intervention group
Group type: EXPERIMENTAL
Intervention: T2-T4 research in 2018
Number of subjects: 2046
Study 33436117 — intervention group
Group type: EXPERIMENTAL
Intervention: T2-T4 research in 1998
Number of subjects: 2046
Study 33436117 — intervention group
Group type: EXPERIMENTAL
Intervention: T3/T4 research
Number of subjects: 2046
Study 35352668 — intervention group
Group type: EXPERIMENTAL
Intervention: Peri-urethral injection of autologous mucosa stem cells
Number of subjects: 30
Study 35352668 — intervention group
Group type: COMPARATOR
Intervention: Mini-sling insertion
Number of subjects: 30
Study 33637835 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-generation antipsychotic (risperidone or paliperidone)
Number of subjects: 62
Study 33637835 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 33637835 — intervention group
Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 62
Study 36131307 — intervention group
Group type: EXPERIMENTAL
Intervention: Training intervention to improve the management of vertigo in primary care
Number of subjects: 0
Study 33769293 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended Acceptance and Commitment Therapy (ACT)
Number of subjects: 314
Study 33769293 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face Cognitive Behavioral Therapy (CBT)
Number of subjects: 314
Study 35435943 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin treatment
Number of subjects: 0
Study 35435943 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 33303934 — intervention group
Group type: EXPERIMENTAL
Intervention: Tape measure for Fingertip-to-Floor test (FtF)
Number of subjects: 22
Study 33303934 — intervention group
Group type: EXPERIMENTAL
Intervention: Tape measure for Lateral Inclination test (LI)
Number of subjects: 22
Study 33303934 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital inclinometer for Retroflexion of the trunk (RF)
Number of subjects: 22
Study 33303934 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital inclinometer for Shoulder test (ST)
Number of subjects: 22
Study 33303934 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital inclinometer for Thomas test (TT)
Number of subjects: 22
Study 33073745 — intervention group
Group type: EXPERIMENTAL
Intervention: DBT + CALMA
Number of subjects: 18
Study 33073745 — intervention group
Group type: COMPARATOR
Intervention: DBT
Number of subjects: 18
Study 32791318 — intervention group
Group type: EXPERIMENTAL
Intervention: PriCARE intervention
Number of subjects: 174
Study 32791318 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 174
Study 32791318 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 174
Study 34742136 — intervention group
Group type: EXPERIMENTAL
Intervention: n3 PUFA (930 mg EPA + 660 mg DHA)
Number of subjects: 156
Study 34742136 — intervention group
Group type: COMPARATOR
Intervention: Corn oil (placebo)
Number of subjects: 156
Study 32089006 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab (75-150 mg every 2 weeks)
Number of subjects: 4983
Study 32089006 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo/ezetimibe)
Number of subjects: 4983
Study 32089006 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab
Number of subjects: 4983
Study 35239547 — intervention group
Group type: EXPERIMENTAL
Intervention: 1600 mg single-dose oral cannabidiol
Number of subjects: 24
Study 35239547 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 33076885 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 138
Study 33076885 — intervention group
Group type: COMPARATOR
Intervention: Prednisone
Number of subjects: 138
Study 35759877 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal speech-gesture (MSG) training
Number of subjects: 29
Study 35759877 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 29
Study 35759877 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 29
Study 32053276 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulins (IVIg)
Number of subjects: 179
Study 32053276 — intervention group
Group type: COMPARATOR
Intervention: Careful observation
Number of subjects: 179
Study 36427629 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive computerized cognitive training
Number of subjects: 90
Study 36427629 — intervention group
Group type: COMPARATOR
Intervention: Non-adaptive computerized cognitive training
Number of subjects: 90
Study 36427629 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined arms (adaptive and non-adaptive)
Number of subjects: 90
Study 32800818 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared-care clinic attendance (n=21)
Number of subjects: 42
Study 32800818 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 42
Study 32800818 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared-care clinic
Number of subjects: 42
Study 34859422 — intervention group
Group type: EXPERIMENTAL
Intervention: Zhang's guideline
Number of subjects: 3604
Study 34859422 — intervention group
Group type: COMPARATOR
Intervention: WHO partograph
Number of subjects: 3604
Study 36264696 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdisciplinary discharge planning
Number of subjects: 70
Study 36264696 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard discharge planning)
Number of subjects: 70
Study 34805400 — intervention group
Group type: EXPERIMENTAL
Intervention: Aram Video Stylet
Number of subjects: 30
Study 34805400 — intervention group
Group type: COMPARATOR
Intervention: McGrath® MAC video laryngoscope
Number of subjects: 30
Study 36139496 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic mixture containing Bifidobacterium longum, Lactobacillus helveticus, and Lactiplantibacillus plantarum
Number of subjects: 22
Study 36139496 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic mixture
Number of subjects: 22
Study 32653074 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-dose MF–IND–GLY (80 μg, 150 μg, 50 μg)
Number of subjects: 3092
Study 32653074 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose MF–IND–GLY (160 μg, 150 μg, 50 μg)
Number of subjects: 3092
Study 34218336 — intervention group
Group type: EXPERIMENTAL
Intervention: PR-ESSENCE intervention
Number of subjects: 108
Study 34218336 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 108
Study 34214682 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonviable probiotic lysate (BL) of Escherichia coli (DSM 17252) and Enterococcus faecalis (DSM 16440)
Number of subjects: 389
Study 34214682 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 389
Study 32531956 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent fasting (IF) - complete abstinence from food intake for 16 hours per day (20:00 p.m. to 12:00 a.m.)
Number of subjects: 45
Study 32531956 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-restricted feeding (TRF)
Number of subjects: 45
Study 35341180 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimedia badminton teaching (experimental class)
Number of subjects: 82
Study 35341180 — intervention group
Group type: COMPARATOR
Intervention: Traditional badminton teaching (control class)
Number of subjects: 82
Study 33161162 — intervention group
Group type: COMPARATOR
Intervention: Minocycline treatment
Number of subjects: 207
Study 32289681 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS (2 mA, 20 min)
Number of subjects: 39
Study 32289681 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 39
Study 33970358 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypofractionated radiotherapy (HFRT)
Number of subjects: 0
Study 33970358 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial breast irradiation (PBI)
Number of subjects: 0
Study 32569284 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback-enhanced therapeutic exercise video game intervention
Number of subjects: 19
Study 36498437 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive educational program led by nurses
Number of subjects: 131
Study 36498437 — intervention group
Group type: COMPARATOR
Intervention: Routine health education and follow-up
Number of subjects: 131
Study 32662833 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga or Physical Therapy (PT)
Number of subjects: 299
Study 32662833 — intervention group
Group type: COMPARATOR
Intervention: Self-care book
Number of subjects: 299
Study 32662833 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 299
Study 32662833 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Therapy (PT)
Number of subjects: 299
Study 32662833 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga or PT (with pain medication)
Number of subjects: 299
Study 32662833 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga or PT (without pain medication)
Number of subjects: 299
Study 32662833 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga or PT (with low fear avoidance beliefs)
Number of subjects: 299
Study 32662833 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga or PT (with high fear avoidance beliefs)
Number of subjects: 299
Study 32800383 — intervention group
Group type: EXPERIMENTAL
Intervention: Surufatinib 250 mg capsules in the fasted state
Number of subjects: 24
Study 32800383 — intervention group
Group type: EXPERIMENTAL
Intervention: Surufatinib 250 mg capsules in the fed state
Number of subjects: 24
Study 32800383 — intervention group
Group type: EXPERIMENTAL
Intervention: Surufatinib 250 mg capsules (both fasted and fed states)
Number of subjects: 24
Study 35180798 — intervention group
Group type: EXPERIMENTAL
Intervention: Plastic stent
Number of subjects: 104
Study 35180798 — intervention group
Group type: COMPARATOR
Intervention: No stent
Number of subjects: 104
Study 34435440 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS+PN
Number of subjects: 752
Study 34435440 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS-only
Number of subjects: 752
Study 33026755 — intervention group
Group type: EXPERIMENTAL
Intervention: HQ 4%
Number of subjects: 18
Study 33026755 — intervention group
Group type: EXPERIMENTAL
Intervention: CTB
Number of subjects: 18
Study 33207981 — intervention group
Group type: EXPERIMENTAL
Intervention: Caretoon approach (illustrated and curiosity-driven public engagement campaign)
Number of subjects: 18788
Study 33207981 — intervention group
Group type: COMPARATOR
Intervention: Standard approach (non-illustrated ad and survey)
Number of subjects: 18788
Study 35633431 — intervention group
Group type: COMPARATOR
Intervention: Testosterone treatment for one year in men aged ≥ 65 years
Number of subjects: 1795
Study 35633431 — intervention group
Group type: COMPARATOR
Intervention: Testosterone treatment for two years in men aged 50–74 years
Number of subjects: 1795
Study 33276013 — intervention group
Group type: EXPERIMENTAL
Intervention: INSIGHT Responsive Parenting (RP) intervention
Number of subjects: 232
Study 33276013 — intervention group
Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 232
Study 34117564 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% hydrogen peroxide gel (35% HP, commercial gel)
Number of subjects: 40
Study 34117564 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% HP with 2% chitosan (35% HP + chitosan)
Number of subjects: 40
Study 34117564 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% HP and calcium (35% HP + Ca, commercial gel)
Number of subjects: 40
Study 34117564 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% HP + Ca + 2% chitosan
Number of subjects: 40
Study 34117564 — intervention group
Group type: COMPARATOR
Intervention: Negative control (unbleached)
Number of subjects: 40
Study 34013852 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual Cognitive Behavioural Therapy (ICBT)
Number of subjects: 165
Study 34013852 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Cognitive Behavioural Therapy (GCBT)
Number of subjects: 165
Study 34106473 — intervention group
Group type: EXPERIMENTAL
Intervention: Short 3-item version of the Montreal Cognitive Assessment (MoCA) administered by telephone
Number of subjects: 1069
Study 32073990 — intervention group
Group type: EXPERIMENTAL
Intervention: PRP+CDP
Number of subjects: 45
Study 32073990 — intervention group
Group type: EXPERIMENTAL
Intervention: LLLT+CDP
Number of subjects: 45
Study 32073990 — intervention group
Group type: COMPARATOR
Intervention: CDP
Number of subjects: 45
Study 32213163 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex (2 mg/kg)
Number of subjects: 41
Study 32213163 — intervention group
Group type: COMPARATOR
Intervention: Neostigmine (50 mcg/kg plus 10 mcg/kg of atropine)
Number of subjects: 41
Study 35833308 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative pressure wound therapy
Number of subjects: 221
Study 35833308 — intervention group
Group type: COMPARATOR
Intervention: Conventional wound treatment
Number of subjects: 221
Study 33440046 — intervention group
Group type: EXPERIMENTAL
Intervention: Exclusive enteral nutrition (EEN) for 7 days along with standard of care (SOC)
Number of subjects: 62
Study 33440046 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 62
Study 35452417 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin (Cur)
Number of subjects: 107
Study 35452417 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen
Number of subjects: 107
Study 35452417 — intervention group
Group type: COMPARATOR
Intervention: Wnt/β‐catenin pathway inhibitors
Number of subjects: 107
Study 33377185 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 123
Study 33377185 — intervention group
Group type: COMPARATOR
Intervention: Non-Levosimendan (Control)
Number of subjects: 123
Study 35585593 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared meditation intervention (12 weekly sessions of 1.5 hours and a half-day retreat)
Number of subjects: 30
Study 32644104 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorouracil-based nCRT
Number of subjects: 1232
Study 32644104 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorouracil-based nCRT with oxaliplatin
Number of subjects: 1232
Study 32644104 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorouracil-based adjuvant chemotherapy
Number of subjects: 1232
Study 32644104 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorouracil-based adjuvant chemotherapy with oxaliplatin
Number of subjects: 1232
Study 34848127 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior tibial and sural nerve blocks with bupivacaine
Number of subjects: 48
Study 34848127 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 48
Study 34528723 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemafibrate 0.2 mg, orally, twice daily for 72 weeks
Number of subjects: 118
Study 34528723 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study 35034194 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting-Mimicking Diet (FMD)
Number of subjects: 24
Study 35034194 — intervention group
Group type: COMPARATOR
Intervention: Normal Diet (ND)
Number of subjects: 24
Study 33413727 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5 g of salmon fish protein/d
Number of subjects: 88
Study 33413727 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study 35333140 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive interdisciplinary and virtual review of patients discharged after hospitalization for COPD exacerbation
Number of subjects: 352
Study 35333140 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 352
Study 32894231 — intervention group
Group type: EXPERIMENTAL
Intervention: DynamX Novolimus‐Eluting Coronary Bioadaptor System
Number of subjects: 50
Study 35712916 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided Self-Help (GSH) program, 14 individual sessions over 6 months, 5.3 hours of treatment
Number of subjects: 164
Study 35712916 — intervention group
Group type: COMPARATOR
Intervention: Family-based behavioral treatment (FBT), 20 group-based sessions over 6 months, 20 hours of treatment
Number of subjects: 164
Study 35712916 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined results from both groups
Number of subjects: 164
Study 32381793 — intervention group
Group type: EXPERIMENTAL
Intervention: 660 nm diode laser applied for 1 minute on the surgical site
Number of subjects: 50
Study 32381793 — intervention group
Group type: COMPARATOR
Intervention: Control group (no laser application)
Number of subjects: 50
Study 36396443 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactoferrin
Number of subjects: 479
Study 36396443 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 479
Study 33401238 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (6 mg·kg‐1 of body mass)
Number of subjects: 14
Study 33401238 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sucrose)
Number of subjects: 14
Study 32129558 — intervention group
Group type: EXPERIMENTAL
Intervention: ATOP Psychological Health
Number of subjects: 128
Study 32129558 — intervention group
Group type: EXPERIMENTAL
Intervention: ATOP Physical Health
Number of subjects: 128
Study 32129558 — intervention group
Group type: EXPERIMENTAL
Intervention: ATOP Quality of Life
Number of subjects: 128
Study 32129558 — intervention group
Group type: EXPERIMENTAL
Intervention: ATOP substance use, employment, education and child care items
Number of subjects: 128
Study 32129558 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobacco use, Psychological Health, Physical Health and Quality of Life
Number of subjects: 128
Study 35691974 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha/Theta Ratio Neurofeedback Training (ATR NFT), 10 sessions, 2-3 sessions per week
Number of subjects: 8
Study 34387126 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac neuromodulation therapy (CNT)
Number of subjects: 47
Study 34387126 — intervention group
Group type: COMPARATOR
Intervention: CNT inactive (Control)
Number of subjects: 47
Study 32303203 — intervention group
Group type: EXPERIMENTAL
Intervention: Alerta Alcohol programme (intervention group)
Number of subjects: 1247
Study 32303203 — intervention group
Group type: COMPARATOR
Intervention: No active intervention (control group)
Number of subjects: 1247
Study 36253171 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-implemented repeated reading training (RR group)
Number of subjects: 22
Study 36253171 — intervention group
Group type: COMPARATOR
Intervention: General training based on a summer vacation workbook (SVW group)
Number of subjects: 22
Study 33494831 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided online intervention (6-week duration)
Number of subjects: 18
Study 33494831 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control (6-week duration)
Number of subjects: 18
Study 36038256 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study 36038256 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg/kg/day caffeine citrate
Number of subjects: 132
Study 36038256 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/kg/day caffeine citrate
Number of subjects: 132
Study 36038256 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg/kg/day caffeine citrate
Number of subjects: 132
Study 36038256 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg/kg/day caffeine citrate
Number of subjects: 132
Study 34018006 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular steroid injection of triamcinolone acetonide (Kenalog)
Number of subjects: 1471
Study 33001143 — intervention group
Group type: EXPERIMENTAL
Intervention: Dostarlimab 500 mg intravenously every 3 weeks for 4 doses, then 1000 mg every 6 weeks until disease progression, treatment discontinuation, or withdrawal
Number of subjects: 104
Study 33001143 — intervention group
Group type: EXPERIMENTAL
Intervention: Dostarlimab
Number of subjects: 104
Study 32170761 — intervention group
Group type: EXPERIMENTAL
Intervention: HBV integration at the TERT promoter
Number of subjects: 95
Study 32170761 — intervention group
Group type: EXPERIMENTAL
Intervention: HBV enhancer I (EnhI)
Number of subjects: 95
Study 32170761 — intervention group
Group type: EXPERIMENTAL
Intervention: Stable knockdown of ELF4
Number of subjects: 95
Study 35373274 — intervention group
Group type: EXPERIMENTAL
Intervention: Trametinib (MEK1/2 inhibitor)
Number of subjects: 0
Study 34830632 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time dosimetry monitoring system (Raysafe)
Number of subjects: 700
Study 34830632 — intervention group
Group type: COMPARATOR
Intervention: Standard radiation shield alone (control group)
Number of subjects: 700
Study 33122670 — intervention group
Group type: EXPERIMENTAL
Intervention: Circadian misalignment (simulated night shifts)
Number of subjects: 0
Study 35658685 — intervention group
Group type: EXPERIMENTAL
Intervention: Wound closure with a vessel loop (n = 19)
Number of subjects: 47
Study 35658685 — intervention group
Group type: COMPARATOR
Intervention: Wound closure without a vessel loop (standard, n = 28)
Number of subjects: 47
Study 32591417 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% lidocaine spray
Number of subjects: 124
Study 35699261 — intervention group
Group type: COMPARATOR
Intervention: NRD.E1 (300 to 1200 mg single dose)
Number of subjects: 0
Study 35699261 — intervention group
Group type: COMPARATOR
Intervention: NRD.E1 (300 mg once daily for 5 days)
Number of subjects: 0
Study 35699261 — intervention group
Group type: EXPERIMENTAL
Intervention: NRD.E1 (40 mg under fed and fasted conditions)
Number of subjects: 0
Study 33627370 — intervention group
Group type: EXPERIMENTAL
Intervention: Insomnia prevention program (4 weekly sessions)
Number of subjects: 242
Study 33627370 — intervention group
Group type: COMPARATOR
Intervention: Nonactive control group
Number of subjects: 242
Study 35672057 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy following a dose adjusted EPOCH‐R regimen
Number of subjects: 1
Study 32179059 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin administration
Number of subjects: 0
Study 32179059 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 0
Study 33279779 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesalamine induction therapy
Number of subjects: 726